Vanessa L Gates
Overview
Explore the profile of Vanessa L Gates including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
2010
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gordon A, Gates V, White S, Harris K, Mouli S, Kim D, et al.
J Vasc Interv Radiol
. 2021 Oct;
32(11):1569-1574.e11.
PMID: 34717835
The purpose of this study was to define the optimal infusion parameters and operator radiation exposure for yttrium-90 (Y) radioembolization in the VX2 rabbit model of liver cancer. Forty-one rabbits...
2.
Mouli S, Raiter S, Harris K, Mylarapu A, Burks M, Li W, et al.
J Vasc Interv Radiol
. 2021 Apr;
32(8):1103-1112.e12.
PMID: 33839262
Purpose: To investigate the feasibility, safety, and absorbed-dose distribution of prostatic artery radioembolization (RE) in a canine model. Materials And Methods: Fourteen male castrated beagles received dihydroandrosterone/estradiol to induce prostatic...
3.
Gordon A, Gates V, White S, Harris K, Procissi D, Zhang Z, et al.
J Vasc Interv Radiol
. 2020 Nov;
32(1):23-32.e1.
PMID: 33189539
Purpose: To demonstrate a stronger correlation and agreement of yttrium-90 (Y) positron emission tomography (PET)/computed tomography (CT) measurements with explant liver tumor dosing compared with the standard model (SM) for...
4.
Gordon A, White S, Gates V, Li W, Procissi D, Zhang Z, et al.
Cardiovasc Intervent Radiol
. 2020 Aug;
43(12):1925-1935.
PMID: 32803285
Purpose: Portal vein embolization (PVE) is an established neoadjuvant method to induce future liver remnant hypertrophy prior to surgical resection of hepatic tumors. The purpose of our study was to...
5.
Gordon A, White S, Yang Y, Gates V, Procissi D, Harris K, et al.
Cardiovasc Intervent Radiol
. 2020 Jun;
43(10):1528-1537.
PMID: 32533312
Purpose: To evaluate the combination of Y radioembolization (Y90) and drug-eluting bead irinotecan (DEBIRI) microspheres in the VX2 rabbit model. Materials And Methods: An initial dose finding study was performed...
6.
Gordon A, White S, Gates V, Procissi D, Harris K, Yang Y, et al.
Acad Radiol
. 2020 Jun;
28(6):849-858.
PMID: 32522403
Rationale And Objectives: To use a rapid gas-challenge blood oxygen-level dependent magnetic resonance imaging exam to evaluate changes in tumor hypoxia after Y radioembolization (Y90) in the VX2 rabbit model....
7.
Gabr A, Ranganathan S, Mouli S, Riaz A, Gates V, Kulik L, et al.
J Hepatol
. 2020 Mar;
72(6):1151-1158.
PMID: 32145255
Background & Aims: Pre-treatment Tc-99m macroaggregated albumin (MAA) scans are routinely performed prior to transarterial radioembolization (TARE) to estimate lung shunt fraction (LSF) and lung dose. In this study, we...
8.
Su Y, Mackey R, Riaz A, Gates V, Benson 3rd A, Miller F, et al.
J Vasc Interv Radiol
. 2017 Jul;
28(11):1520-1526.
PMID: 28673658
Purpose: To determine long-term hepatotoxicity of yttrium-90 (Y) radioembolization in patients treated for metastatic neuroendocrine tumor (mNET) and evaluate if imaging and laboratory findings of cirrhosis-like morphology are associated with...
9.
Kallini J, Gabr A, Hickey R, Kulik L, Desai K, Yang Y, et al.
Cardiovasc Intervent Radiol
. 2017 Mar;
40(8):1213-1222.
PMID: 28280976
Purpose: To determine the correlation of pre-procedural and imaging characteristics with lung shunt fraction (LSF) measured by technetium-99 m macroaggregated albumin (Tc-MAA) scan in patients with hepatocellular carcinoma. Methods: A...
10.
Padia S, Lewandowski R, Johnson G, Sze D, Ward T, Gaba R, et al.
J Vasc Interv Radiol
. 2016 Nov;
28(1):1-15.
PMID: 27836405
No abstract available.